RT Journal Article
T1 Modulating immunosuppression in liver transplant patients with COVID-19.
A1 Rodriguez-Peralvarez, Manuel
A1 Salcedo, Magdalena
A1 Colmenero, Jordi
A1 Pons, Jose Antonio
K1 Immunoregulation
K1 Liver transplantation
AB We read with great interest the COVID-LT study by C Becchetti et al.Which included 57 liver transplant (LT) patients from 12 European institutions who were diagnosed with coronavirus disease 2019 (COVID-19). Simultaneously, the Spanish Society of Liver Transplantation (SETH) has conducted a nationwide prospective study including 22 transplant institutions and 111 LT patients with COVID-19. Since there were only nine overlapped cases, both cohorts add up to 159 LT patients and taken together their close analysis (table 1) may derive in practical conclusions.
PB BMJ Group
YR 2020
FD 2020-08-11
LK http://hdl.handle.net/10668/16119
UL http://hdl.handle.net/10668/16119
LA en
NO Rodriguez-Peralvarez M, Salcedo M, Colmenero J, Pons JA. Modulating immunosuppression in liver transplant patients with COVID-19. Gut. 2021 Jul;70(7):1412-1414
DS RISalud
RD Apr 4, 2025